Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors von Zhaleiko, I.O., Perekhrestenko, T.P., Bilko, D.I., Dyagil, I.S., Bilko, N.M.

Volltext

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy von Sviezhentseva, I.O., Perekhrestenko, T.P., Bilko, D.I., Gordienko, A.I., Diachenko, M.V., Dyagil, I.S.

Volltext